I was made redundant two months ago <a href=" http://iibf.uludag.edu.tr/?buy-indocin-online.pdf ">buy indomethacin nz</a> There was a high rate of adverse events in the Phase III study, but nothing that pointed to alirocumab as a particular problem, with 78% in the Zetia group experiencing a problem and 69% in the alirocumab arm reporting trouble. The most common problem was infection, but Zetia proved close to alirocumab with a 39% rate compared to 42% for the experimental group.